Short answer
Core Laboratories Inc. /DE/ (CLB) filed an 8-K current report with the SEC on March 17, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Tax restatement: income tax expense understated by $4.2M for Q4 and full-year 2025, reducing net income by same amount.
Core Laboratories Inc. /DE/ 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Tax restatement: income tax expense understated by $4.2M for Q4 and full-year 2025, reducing net income by same amount
- Diluted EPS revised down $0.09/share for both Q4 and full-year 2025
- Error source: deferred tax timing difference tied to insurance proceeds from Aberdeen, U.K. facility fire damage
- Additional 2024 balance sheet corrections: $4.7M misclassification and $5.6M write-off of unrecoverable pre-2021 tax receivables, charged to beginning retained earnings
- No impact on revenue, operating income, income before tax, or cash from operations: restatement is tax/non-cash only; 10-K expected ~March 17, 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Core Laboratories Inc. /DE/ 8-K filings
Get the next CLB 8-K as it lands
Follow CLB for push alerts, or ask the research agent what this filing means.